Log in
Enquire now
‌

US Patent 10125353 Recombinant therapeutic glycine N-acyltransferase

Patent 10125353 was granted and assigned to North-West University on November, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
North-West University
North-West University
0
Current Assignee
North-West University
North-West University
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
101253530
Patent Inventor Names
Rencia Van Der Sluis0
Alberdina Aike Van Dijk0
Christoffel Petrus Stephanus Badenhorst0
Lodewyk Jacobus Mienie0
Date of Patent
November 13, 2018
0
Patent Application Number
152742340
Date Filed
September 23, 2016
0
Patent Primary Examiner
‌
Richard C Ekstrom
0
Patent abstract

This invention relates to a method of producing a recombinant enzyme, more particularly, this invention relates to a method of producing water soluble enzymatically active recombinant glycine N-acyltransferase (GLYAT (E.G. 2.1.3.13)), including the steps of providing a suitable expression host; preparing a vector including a gene for expressing GLYAT in the expression host to form an expression plasmid; transforming the host with the expression plasmid to form an expression system; expressing the GLYAT gene in the expression system; and separating the expressed GLYAT from the expression system.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10125353 Recombinant therapeutic glycine N-acyltransferase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.